Aclarion, Inc. Files Q1 2025 10-Q
Ticker: ACONW · Form: 10-Q · Filed: May 15, 2025 · CIK: 1635077
| Field | Detail |
|---|---|
| Company | Aclarion, INC. (ACONW) |
| Form Type | 10-Q |
| Filed Date | May 15, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, medical-laboratories
Related Tickers: ACON
TL;DR
Aclarion (ACON) filed its Q1 2025 10-Q. Financials are in.
AI Summary
Aclarion, Inc. filed its 10-Q for the period ending March 31, 2025. The company, formerly Nocimed, Inc., is incorporated in Delaware and operates in the medical laboratories sector. Its principal executive offices are located in Broomfield, Colorado.
Why It Matters
This filing provides investors with the company's financial performance and operational details for the first quarter of 2025, crucial for understanding its current business standing.
Risk Assessment
Risk Level: low — This is a standard quarterly financial filing with no immediate red flags.
Key Players & Entities
- Aclarion, Inc. (company) — Filer of the 10-Q
- Nocimed, Inc. (company) — Former name of Aclarion, Inc.
- 20250331 (date) — Period of report for the 10-Q
- 8071 (industry_code) — Standard Industrial Classification for Medical Laboratories
- 833 275 2266 (phone_number) — Business phone number for Aclarion, Inc.
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20250331, indicating the filing covers the first quarter of 2025.
What was Aclarion, Inc.'s former name?
Aclarion, Inc. was formerly known as Nocimed, Inc., with a date of name change on 20150226.
Where is Aclarion, Inc. headquartered?
Aclarion, Inc.'s business and mail address is 8181 Arista Place, Ste 100, Broomfield, CO 80021.
What is Aclarion, Inc.'s Standard Industrial Classification code?
Aclarion, Inc. falls under SIC code 8071, which is for SERVICES-MEDICAL LABORATORIES.
When was this 10-Q filing submitted?
This filing was submitted on 20250515.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 15, 2025 regarding Aclarion, Inc. (ACONW).